
|Articles|March 1, 2012
- Pharmaceutical Executive-03-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - March 2012
Leading in Emerging Markets
Advertisement
Articles in this issue
almost 14 years ago
Novartis: LEADing in Emerging Marketsalmost 14 years ago
How Can We Fix the FDA?almost 14 years ago
The Italian's Jobalmost 14 years ago
Off the Hook? Pharm Exec's Annual Press Auditalmost 14 years ago
The Maestrosalmost 14 years ago
The (Life) Science of Digital Connectionsalmost 14 years ago
Judging a Pill by its Coveralmost 14 years ago
When Talk is Not So CheapNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
2
JP Morgan 2026: AbbVie Advances its Pipeline
3
What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan Healthcare Conference?
4
Novartis Calls for Global Governments to Address Global Trade Policy
5




